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R2-recanalization of spontaneous carotid artery dissection
Abstract
BACKGROUND AND PURPOSE: We set out to investigate the predictors and time course for
recanalization of spontaneous dissection of the cervical internal carotid artery (SICAD). METHODS:
We prospectively included 249 consecutive patients (mean age, 45+/-11 years) with 268 SICAD.
Ultrasound examinations were performed at presentation, during the first month, and then at 3, 6, and 12
months, and clinical follow-ups after 3, 6, and 12 months. RESULTS: Of 268 SICADs, 20 (7.5%)
presented with </=50% stenosis, 31 (11.6%) with 51% to 80% stenosis, 92 (34.3%) with 81% to 99%
stenosis, and 125 (46.6%) with an occlusion. Antithrombotic treatment included anticoagulation in 174
(67%) patients, aspirin in 64 (24%) patients, and aspirin followed by anticoagulation or vice versa in 22
(8%) patients. Follow-up ultrasound showed normal findings in 160 (60%), </=50% stenosis in 27
(10%), 51% to 80% stenosis in 4 (1%), 81% to 99% stenosis in 26 (10%), and occlusion in 51 (19%)
vessels. The rate of complete recanalization was 16% at 1 month, 50% at 3 months, and 60% at 6 and 12
months. Initial occlusion of the dissected vessels reduced the odds of recanalization (OR, 4.0; 95% CI,
2.2-7.3; P<0.001), whereas the occurrence of local symptoms and signs only at presentation were
independently associated with complete recanalization (OR, 0.4; 95% CI, 0.2-0.8; P=0.048).
CONCLUSIONS: These results suggest that recanalization of SICAD occurs mainly within the first 6
months after the onset of symptoms. Initial occlusion reduces the likelihood of complete recanalization,
whereas presentation with local symptoms and signs only increases it.
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Abstract 
Background: We set out to investigate the predictors and time course for recanalization of 
spontaneous dissection of the cervical internal carotid artery (SICAD). 
Methods: 249 consecutive patients (mean age, 45±11 years) with 268 SICAD were 
prospectively included. Ultrasound examinations were carried out at presentation, during the 
first month, and then at 3, 6 and 12 months, and clinical follow-ups after 3, 6 and 12 months.  
Results: Of 268 SICAD, 20 (7.5%) presented with a ≤50% stenosis, 31 (11.6%) with a 51-80% 
stenosis, 92 (34.3%) with an 81-99% stenosis, and 125 (46.6%) with an occlusion. 
Antithrombotic treatment included anticoagulation in 174 (67%) patients, aspirin in 64 (24%) 
patients, and aspirin followed by anticoagulation or vice versa in 22 (8%) patients. Follow-up 
ultrasound showed normal findings in 160 (60%), a ≤50% stenosis in 27 (10%), a 51-80% 
stenosis in 4 (1%), an 81-99% stenosis in 26 (10%), and an occlusion in 51 (19%) vessels. The 
rate of complete recanalization was 16% at 1 month, 50% at 3 months, and 60% at 6 and 12 
months. Initial occlusion of the dissected vessels reduced the odds of recanalization (OR 4.0, 
95% CI 2.2–7.3, P<0.001) while the occurrence of local symptoms and signs only at 
presentation were independently associated with complete recanalization (OR 0.4, 95% CI 0.2–
0.8, P=0.048).  
Conclusions: These results suggest that recanalization of SICAD occurs mainly within the first 
6 months after the onset of symptoms. Initial occlusion reduces the likelihood of complete 
recanalization, whilst presentation with local symptoms and signs only increases it. 
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Spontaneous dissection of the cervical internal carotid artery (SICAD) is a frequent cause of 
stroke in young to middle aged patients 1, 2. The main mechanism is arterio-arterial embolism 3, 
4, and most clinicians recommend the administration of anticoagulants or aspirin for stroke 
prevention 5, 6. To enable a more sophisticated antithrombotic treatment of patients with 
spontaneous cervical artery dissection, the CADISP group reviewed recently the mechanism of 
brain ischemia, clinical experiences, and a systematic meta-analysis about antithrombotic agents 
in these patients32. There is however no consensus about the duration of antithrombotic 
treatment. Many clinicians feel that antithrombotic therapy is no longer necessary once the flow 
in the dissected artery is reestablished 7. 
Combined extra- and transcranial ultrasound is useful, in particular in patients presenting with 
carotid territory ischemia for assessing carotid stenosis and occlusion in patients with SICAD, 
both in the acute phase and during recanalization 8, 9.  
We undertook this study to investigate the predictors and the time course of recanalization of the 
cervical internal carotid artery using ultrasound in patients with SICAD. 
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METHODS 
Consecutive patients who presented with SICAD at two university-based stroke centers (Zurich 
and Bern) were prospectively included in a database from October 1992 until October 2005. The 
diagnosis of SICAD was based on imaging findings (cervical MRI and MR angiography 
(MRA), digital subtraction angiography (DSA), or both). Carotid dissection was considered 
proven if the cervical ICA showed a string sign, an intimal flap or an aneurysm at angiography, 
a wall hematoma at cervical MRI, or both 10. Patients with a narrowed or occluded cervical ICA 
on the initial ultrasound were included. Patients were excluded, if they underwent thrombolytic 
therapy for acute stroke, surgical or endovascular treatments for SICAD. Furthermore, SICAD 
recurring in a previously dissected carotid artery was not analyzed.  
Baseline investigations have been reported before 3 and include neurological and physical 
examinations, routine blood analysis, 12-lead ECG, ultrasound studies of the cerebral arteries, 
and cerebral CT, MRI, or both in patients with stroke or transient ischemic attacks (TIA).   
The following stroke risk factors were assessed: age; sex; hypertension (defined as a history of 
hypertension (systolic blood pressure [BP] >160 mm Hg, diastolic BP >90 mm Hg until 
September 2000, and systolic BP >140 mm Hg, diastolic BP >85 mm Hg since October 2000 11) 
measured on two separate occasions, or antihypertensive treatment, or both); diabetes mellitus 
(defined by preadmission history or venous plasma glucose concentration of ≥7.0 mmol/l after 
an overnight fast on at least two separate occasions, and/or ≥11.1 mmol/l two hours after oral 
ingestion of 75 g glucose and on one other occasion during the 2-hour test), current cigarette 
smoking, hypercholesterolemia (defined by preadmission history and/or total cholesterol (TC) 
concentration >5 mmol/l, LDL-cholesterol concentration >3 mmol/l, TC/HDL ratio > 5), 
increased HDL-cholesterol levels (defined by HDL-cholesterol concentration <1 mmol/l), 
coronary artery disease, and migraine.                    
Patients were categorized according to the presenting signs and symptoms into 5 groups: a) 
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stroke (ischemic deficit lasting > 24 hours), b) TIA (ischemic deficit lasting < 24 hours), c) 
amaurosis fugax or retinal infarction, d) one or several of the following local symptoms and 
signs: headache, neck pain, pulsatile tinnitus, Horner’s Syndrome or cranial nerve palsy on the 
side of SICAD, e) asymptomatic. Stroke severity on admission was assessed with the National 
Institute of Health Stroke Scale (NIHSS) 12.  
Ultrasound studies were performed with the same equipment (for extra- and transcranial color 
duplex studies Acuson XP 10 or Sequoia, Mountain View, CA, USA; for transorbital Doppler 
studies EME, Überlingen, Germany and since October 1997 Acuson XP 10 or Sequoia, 
Mountain View, CA, USA). Extracranial color duplex sonography of the ICA at the origin, the 
external and common (CCA) carotid arteries was done with linear probes (5-8 MHz), and of the 
cervical ICA with sector probes (2.0-3.5 MHz). Transorbital insonation of the ophthalmic 
arteries and the carotid siphon was performed with pulsed-wave Doppler probes (2 MHz) or 
color Doppler sector probes (2.0-3.5 MHz). Transcranial color duplex sonography studies of the 
basal cerebral arteries were performed with sector probes (2.0-3.5 MHz) as reported previously 
13. In brief, the transtemporal approach was used for insonation of the terminal (C1) ICA, 
middle, anterior, precommunicating (P1) and postcommunicating (P2) posterior (PCA) cerebral, 
and anterior communicating arteries (ACoA). Intracranial arteries were investigated for the 
presence of stenoses, occlusions, and cross-flow through the anterior communicating artery 
according to previously published criteria 13-15. Since 1996, all patients with insufficient 
temporal bony windows were also investigated with the echocontrast agent Levovist® using 
concentrations of 400 mg/ml 16, and since July 2005 with the echocontrast agent SonoVue®.  
Stenoses of the cervical ICA were quantified according to the following criteria 8, 10 (Table 1): a 
≤50% stenosis was diagnosed, when intrastenotic peak systolic velocity (PSV) was >90 cm/s in 
women and >80 cm/s in men, and the PSV quotient intrastenotic ICA / contralateral cervical 
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ICA was >1.12 (each reference value was higher than the PSV mean value plus three standarad 
deviations of 78 unpublished own healthy volunteers). A >50% stenosis was diagnosed, when 
intrastenotic PSV was >120 cm/s and the PSV quotient intrastenotic ICA / CCA on the side of 
ICAD (ipsilateral) was >1.5. Intrastenotic velocities are frequently decreased in SICAD causing 
high-grade stenosis 17. To avoid falsely negative findings, only >80% stenoses were diagnosed 
using pre- and poststenotic hemodynamic criteria, and at least two of the following three had to 
be present: (I) The quotient of the resistance index (RI, PSV - peak enddiastolic velocity / PSV) 
ipsilateral CCA / RI contralateral CCA >0.15; (II) reversed flow in the ipsilateral ophthalmic 
artery; (III) cross-flow through the anterior communicating artery. The criteria for 51-80% and 
81-99% ICA stenoses have been published in peer-reviewed journals, developed in studies 
using catheter angiography and the North American Symptomatic Carotid Endarterectomy Trial 
criteria as standard of reference, and elaborated with the same ultrasound equipment used in the 
present study 18-20. The last criterion was used, because different ultrasound machines have been 
shown to measure different flow velocities under identical conditions of examination in both 
flow phantoms and patients 21. ICA occlusion was assessed as reported before 22 (Table 1). 
Ultrasound follow-up examinations to assess recanalization were done within the first month 
after the onset of SICAD symptoms, and after 3, 6 and 12 months. If an ultrasound follow-up 
showed normal findings (i.e. complete recanalization), no further examinations were performed. 
Complete recanalization was diagnosed, when ultrasound showed normal findings, and partial 
recanalization when ultrasound revealed a reduction in the degree of stenosis (from 81-99% to 
51-80% or from 51-80% to ≤50%) or, a change from total occlusion to a stenosis. The time 
interval (days) from SICAD diagnosis to complete recanalization (∆trec) was calculated 
according to the formula: ∆trec = (tn – tp)/2 + (tp – to) , where tn is the time point of the first 
ultrasound examination showing normal findings, tp the time point of the last ultrasound 
examination with pathological findings, and to is the time point of the ultrasound examination at 
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presentation. All ultrasound studies were performed or supervised by an experienced 
sonographer.                             
Choice and duration of antithrombotic treatment was at the discretion of the treating neurologist. 
No selection criteria towards aspirin or anticoagulation were applied. Prior to the publication of 
the International Stroke Trial (IST) in 1997 23, most SICAD patients were treated with 
anticoagulation. Following the publication of the IST results, some neurologists started to treat 
acute strokes caused by SICAD with aspirin. 
Clinical follow-ups were done after 3, 6 and 12 months. In patients with a stroke, 3 month 
functional outcome was assessed using the modified Rankin scale (mRS) 24. The mRS scores of 
0 to 1 were defined as "favorable", and mRS scores of 2 to 6 as "unfavorable" outcome. In 
patients with suspicion of stroke, TIA, retinal ischemia, recurrent dissection, and the occurrence 
of new local symptoms or signs, the diagnostic work-up mentioned above was repeated. During 
3-months follow-up, one patient had suffered a stroke and eight patients a TIA.     
Neurologists or physicians in neurology training certified for NIHSS and mRS assessment 
performed the baseline and the follow-up clinical examinations. The study was approved by the 
local ethics committee. 
Statistical analysis 
Data are reported in frequency tables. The effects of patient characteristics on recanalization 
were assessed using the χ2 test (for comparison of proportions), Student’s t test (for comparison 
of continuous variables), and Mann-Whitney U test (for comparison of ordinal variables). A 
multivariable logistic regression analysis, which included variables that showed statistical 
difference P ≤ 0.1 on univariate comparison, was performed. The Kaplan-Meier method was 
used to determine the likelihood of recanalization at 3, 6 and 12 months. A probability value of 
< 0.05 was considered statistically significant. 
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RESULTS 
Presenting findings 
We evaluated 321 consecutive patients [189 (59%) men; mean age, 46 ± 10 years] with 354 
SICAD. Of the 321 patients with SICAD, 241 (75.1%) presented with symptoms of ischemia 
from the carotid territory, 79 (24.6%) with local symptoms only, and one patient (0.3%) had 
vertigo and the diagnostic work-up detected a SICAD.  
Of 321 patients with SICAD, 72 patients with 86 SICAD were not included as they met at least 
one exclusion criterion (Table 2). Thus, 249 patients [142 (57%) men; mean age, 45 ± 11 years] 
with 268 SICAD were included in the study. 
The presenting clinical characteristics of 160 SICAD (60%) that recanalized completely and 108 
SICAD (40%) that did not recanalize completely during follow-up are shown in Table 3. 
Clinical presentation with local symptoms and signs was more frequent in the group of SICAD 
with complete recanalization (p=0.048). The other presenting clinical characteristics did not 
differ between the two groups. 
The presenting ultrasound findings were assessed after a median delay of 2 days (range, 0 to 58 
days) following the onset of SICAD symptoms, and are shown in Table 4. Of 268 SICAD, 20 
(7.5%) showed a ≤50% stenosis, 31 (11.6%) a 51-80% stenosis, 92 (34.3%) an 81-99% stenosis, 
and 125 (46.6%) an occlusion. A ≤50% stenosis at presentation was more frequent in the group 
of SICAD with complete recanalization at follow-up (P = 0.004). On the contrary, 81%-99% 
stenoses or total occlusions at presentation were more frequent in the group of SICAD without 
complete recanalization. The other ultrasound findings did not differ between the two groups. 
Antithrombotic treatment included anticoagulation in 174 (67%) patients, aspirin in 64 (24%) 
patients, and aspirin followed by anticoagulation or vice versa in 22 (8%) patients. 
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Clinical follow-up 
The functional outcome at 3 months was assessed in 154 (98%) of 157 patients with stroke. A 
favorable outcome (mRS 0 to 1) was observed in 86 (56%) of the 154 patients and was as 
frequent in SICAD with complete recanalization (45 of 84 SICAD, 54%) as in SICAD without 
complete recanalization (41 of 70 SICAD, 58%; P = 0.53). All remaining 68 (44%) patients 
with an unfavorable outcome survived. One patient suffered a spontaneous dissection of the 
contralateral ICA 115 days after the initial SICAD. The second dissection presented with local 
symptoms only. 
Recanalization of SICAD 
All patients underwent a total of 1190 ultrasound studies. At 3 months follow-up, complete 
recanalization was observed in 133 (50%) of 268 SICAD. At 6- and 12-months follow-ups, 
ultrasound showed normal findings in 160 (60%), ≤50% stenosis in 27 (10%), 51-80% stenosis 
in 4 (1%), 81-99% stenosis in 26 (10%), and an occlusion in 51 (19%) SICAD. Two patients 
who had initially a stenosis developed an occlusion. None of these two patients suffered a 
recurrent ischemic event. Carotid recanalization with respect to the degree of the initial stenosis 
is given in Table 5. 
The Kaplan-Meier method was used to determine the likelihood of achieving complete 
recanalization at 1, 3, 6 and 12 months of follow-up (Figure 1). The estimated rate of complete 
recanalization was 15.7% (95% confidence interval (CI), 13.7% - 17.7%) at 1 month, 50.4% 
(95% CI, 47.3% - 53.5%) at 3 months, and 59.7% (95% CI, 56.7% - 62.7%) at 6 and 12 months. 
Predictors of complete recanalization of SICAD 
The P-values for the difference of presenting clinical characteristics between SICAD with and 
without complete recanalization are shown in Table 3. This univariate analysis showed that 
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SICADs with only local symptoms and signs were associated with complete recanalization 
(P=0.048), whereas occluded SICADs were less likely to recanalize (P<0.001). There was a 
trend toward a higher prevalence of complete recanalization in patients treated with 
anticoagulants, though the association did not reach statistical significance (P = 0.064). 
Multivariable logistic regression analysis included the variables that showed statistical 
difference P≤0.1 on univariate comparison, i.e. SICAD with stroke (P=0.051), SICAD with TIA 
(P=0.10), SICAD with local symptoms and signs only (P=0.048), occlusive SICAD (P<0.001), 
and anticoagulation (P=0.064). SICAD with local symptoms and signs only was independently 
associated with complete recanalization (OR 0.4, 95% CI 0.2–0.8, P=0.014), while occlusive 
SICAD reduced the odds of complete recanalization (OR 4.0, 95% CI 2.2–7.3). 
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DISCUSSION 
In this prospective observational study we found that 1) complete recanalization occurred in 160 
(60%) of 268 SICAD, 2) complete recanalization occurred within the first 6 months but not 
thereafter, and 3) occlusive SICAD was less likely to recanalize, whilst SICAD presenting with 
local symptoms and signs only was independently associated with recanalization. 
The 60% complete recanalization rate of SICAD observed in this investigation is similar to the 
results of previous smaller ultrasound studies 9, 22, 25. Steinke et al. observed 48 patients with 50 
SICAD who were treated with anticoagulation for an average period of 51 days 9. Complete 
recanalization was found in 34 (68%) patients. Sturzenegger et al. followed 43 patients with 44 
SICAD during a mean interval of 15 months and reported complete recanalization in 25 (63%) 
of 40 patients 22. Desfontaines et al. surveyed 60 patients with SICAD (spontaneous, n=50; 
traumatic, n=10) who were on anticoagulation in 34 cases for a mean time period of 37.5 
months using ultrasound 25. Complete recanalization of SICAD was observed in 68%. In a 
catheter angiography study, 23 patients with 23 stenotic and 4 occlusive SICAD were restudied 
angiographically after a mean delay of 58.5 months (range, 14-140) 26. Recanalization was 
complete in 13 (48%), partial in 8 (30%) and absent in 6 (22%) vessels. Helical CT was used to 
assess recanalization in 22 SICAD causing carotid stenosis (n=12) or occlusion (n=10) 27. 
Complete recanalization was observed in 21 (95%) of 22 vessels (all stenoses, 9 of 10 
occlusions). The higher rates of complete recanalization reported in these angiography and CT 
studies compared to the present study may be due to several causes: The lower number of 
included patients, the lower relative proportion of patients with occlusive SICAD in the catheter 
angiography study, and possibly an underestimation of the degree of carotid stenosis by helical 
CT. 
Complete recanalization of SICAD was observed in the first 6 months after the onset of 
symptoms but not on later follow-up in our series. These findings are in accordance with the 
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results of previous studies reporting 92%-100% vessel recanalization occurring within 6 months 
22, 25.  
The time course of SICAD recanalization observed in this study supports the current clinical 
practice of many centers including our own: Vascular studies are performed 3 and 6 months 
after the onset of SICAD symptoms, and antithrombotic treatment is administered at least until 
complete recanalization is observed. Many vascular neurologists give long-term low dose oral 
aspirin in SICAD patients with aneurysm in order to prevent thromboembolic events. Under the 
unproven assumption that aspirin is mandatory for stroke prevention in patients with SICAD 
causing an aneurysm, the absence of follow-up MRA for detecting such an aneurysm that 
develops during recanalization may be a limitation of this study. The present study does not 
address the question, whether patients with and without persistent carotid stenosis or occlusion 
due to SICAD should undergo antithrombotic treatment for stroke prevention beyond 6 months 
after symptom onset. An occlusive SICAD was an independent negative predictor of complete 
recanalization, which occurred in 45% of occlusive dissections in this study. These findings are 
in accordance with the results of two previous ultrasound studies 22, 28. Sturzenegger observed a 
complete recanalization in 18 (60%) of 30 occlusive SICAD 22. Another study assessed 
recanalization in 38 patients with acute stroke due to occlusive forms of SICAD (n=19) and 
spontaneous vertebral artery dissection (n=19) 28. Of 38 vessels, 16 (42%) recanalized 
completely within 2 days and 6 weeks after the onset of stroke. The recanalization rate of 
SICAD alone was not reported.  
SICADs causing only local symptoms and signs were independently associated with 
recanalization in our series. In a previous study, SICADs causing carotid territory ischemia 
showed a lower prevalence of Horner’s Syndrome and caudal cranial nerve palsies than SICADs 
causing no ischemic events 10. Furthermore, SICADs with severe stenosis and occlusions caused 
more often carotid territory ischemia than SICADs with less severe stenosis or without stenosis 
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10. One may speculate that SICAD with carotid territory symptoms is more often an inward 
expansion of the wall hematoma, which causes more severe stenosis and occlusion and is less 
likely to recanalize. On the contrary, outward expanding mural hematomas may cause less 
severe stenoses, occlusions and ischemia, but more frequent local symptoms and signs only. 
They are thus associated with higher rates of complete recanalization.  
We did not observe any association between hypertension and the recanalization rate as was 
reported by Caso et al. 28. However, the hypothesis that hypertension damages the elasticity and 
the permeability of the arterial wall is intriguing and deserves further research. 
Previous case reports and small series suggested that anticoagulation might impair 
recanalization of SICAD by increasing the extent of the intramural hematoma 26, 29, 30. In this 
series there was no indication that anticoagulation had a negative impact on carotid 
recanalization. On the contrary, there was a trend towards better recanalization on 
anticoagulants (P=0.064). Interestingly, Engelter et al. observed a trend for higher recanalization 
rates with antiplatelets than with anticoagulants 31. A recent overview about antithrombotic 
treatment of patients with SICAD has been provided by the CADISP group 32. 
In the present study, complete recanalization did not influence the functional outcome in 
patients with stroke, which is in keeping with the findings of acute stroke treatment trials 33 25. 
The present study has some limitations. The choice and duration of antithrombotic therapy was 
not identical for all patients, but at the discretion of the treating physician. The reason is that no 
controlled randomized trial has compared different antithrombotic treatments. Another 
drawback is the heterogeneity with respect to the timing of initial and follow-up ultrasound 
investigations. This limitation, however, was not avoidable, because several predictable facts 
prevented the establishment of a defined timetable for ultrasound studies: It is not possible to 
determine precisely the time of sICAD onset, in particular when diagnosis is not established by 
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cervical MRI; sICAD patients will be out-patients or in-patients with different durations of 
hospital stay, depending on clinical presentation and the severity of the stroke; headache or neck 
pain, which are the most frequent local symptoms, may show the same location, quality and 
intensity compared to previous head or neck pain, and thus prevent the determination of the 
onset of sICAD symptoms; the time interval from symptom onset to arrival in our hospitals is 
significantly longer in patients presenting with local symptom and signs compared to patients 
suffering from ischemia 10. Finally, the time interval from symptom onset to admission has 
decreased in patients with stroke and TIA in the last years, which would have urged us to re-
adapt the timing of the ultrasound studies.  
In conclusion, when complete recanalization of SICAD was achieved it occurred within 6 
months after the onset of symptoms but not thereafter. In addition, non-occlusive SICAD as well 
as SICAD causing local symptoms and signs only were independent predictors of 
recanalization.  
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Table 1. Ultrasound Criteria for Diagnosing Stenosis and Occlusion of the Cervical Internal Carotid 
 
Artery in Patients With Spontaneous Carotid Dissection (for details see text)  
 
 
Carotid stenosis or occlusion 
 
Criterion 
 
 
Stenosis ≤50% 
 
Intrastenotic PSV >90 cm/s (women) and >80 cm/s (men), and 
 
PSV quotient intrastenotic ICA / contralateral cervical ICA >1.12 
 
             51-80% Intrastenotic PSV >120 cm/s, and 
 
PSV quotient intrastenotic ICA / ipsilateral CCA >1.5  
 
             81-99% At least two of the following three criteria have to be fulfilled: 
 
(I) RI quotient ipsilateral CCA / contralateral CCA >0.15, 
 
(II) reversed flow in the ipsilateral ophthalmic artery, 
 
(III) cross-flow through the anterior communicating artery 
 
Occlusion Criteria I-III and in almost all cases criterion IV have to be fulfilled: 
 
(I) absence of detectable flow within the former carotid lumen, 
 
(II) isoechogenic or hypoechogenic, homogeneous or inhomogeneous 
 
material within the former carotid lumen, 
 
(III) indirect signs of due to pre- and postocclusional hemodynamic 
 
alterations (see above stenosis 81-99%), and 
 
(IV) detection of a so-called stump signal directly in front of the 
 
occlusion 
 
 
CCA denotes common carotid artery, contralateral the side opposite to carotid dissection, 
 
ICA internal carotid artery, PSV peak systolic velocity, ipsilateral on the side of carotid dissection, 
 
and  RI the quotient (peak systolic velocity - peak enddiastolic velocity) / peak systolic velocity
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Table 2.  Reasons for Excluding 72 Patients With Spontaneous Carotid Dissection 
 
 Excluded 
patients, n 
Excluded internal carotid 
artery dissections, n 
Normal baseline ultrasound findings  33 40 
Intravenous thrombolysis 16 20 
Intra-arterial thrombolysis 4 4 
Carotid surgery 4 4 
No ultrasound follow-up 15 18 
Death from stroke caused by carotid dissection 8 9 
Recurrent dissection in a carotid artery 0 2 
All 72* 86 
 
* Some patients met more than one exclusion criterion. 
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Table 3. Presenting Clinical Characteristics in 268 Spontaneous Carotid Dissections With and 
 
Without Complete Recanalization Occurring in 249 Patients 
 
Characteristics Complete recanalization, n (%) P-value 
 Yes 
(n=160) 
No 
(n=108) 
 
Mean age ± SD, years 45 ± 10 45 ± 12 0.73 
Male sex 90 (56) 52 (48) 0.19 
Hypertension 43 (27) 25 (23) 0.49 
Diabetes mellitus 2 (1) 1 (1) 0.81 
Current smoking 42 (26) 33 (31) 0.41 
Hypercholesterolemia 58 (36) 35 (32) 0.40 
Coronary artery disease 1 (1) 3 (3) 0.15 
Migraine 15 (9) 15 (14) 0.24 
Minor trauma 34 (21) 16 (15) 0.18 
Stroke  86 (54) 71 (66) 0.051 
Transient ischemic attack 36 (23) 34 (31) 0.10 
Retinal ischemia 21 (13) 14 (13) 1.00 
Local symptoms and signs only 128 (80) 75 (70) 0.048 
Asymptomatic 10 (6) 6 (6) 0.81 
Median NIHSS in stroke patients (range) 10 (1-28) 9 (1-16) 0.97 
Local symptoms and signs include: headache, neck pain, and pulsatile tinnitus, Horner’s Syndrome or 
cranial nerve palsy on the side carotid dissection. NIHSS denotes National Institutes of Health Stroke 
Scale, and P the difference between subgroups by χ2 test, t-test or Mann-Whitney-U test  
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Table 4. Presenting Ultrasound Findings in 268 Spontaneous Carotid Dissections With and 
 
Without Complete Recanalization Occurring in 249 Patients 
 
 
Presenting Characteristic 
 
 
Complete recanalization, n (%) 
 
OR (95%CI) 
 
P-value 
  
Yes (n=160) 
 
 
No (n=108) 
  
 
Left 
 
89 (56) 
 
58 (54) 
  
0.76 
Unilateral 144 (90) 97 (90)  0.96 
Cervical carotid artery     
stenosis ≤50% 18 (11) 2 (2)  6.08 (1.44 – 25.65) 0.004 
              51-80% 19 (12) 12 (11)  1.07 (0.54 – 2.11) 0.85 
              81-90% 67 (42) 25 (23) 1.81 (1.23 – 2.67) 0.002 
occlusion 56 (35) 69 (64) 0.55 (0.43 – 0.71) < 0.001* 
 
CI indicates confidence interval and P the difference between subgroups by χ2 test with regard to 
occlusive spontaneous carotid dissection vs. non-occlusive carotid dissection at presentation.  
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Table 5. Ultrasound Findings Observed at Presentation and at the Last Follow-up in 268 Dissected Carotid Arteries Occurring in 
 
249 Patients 
 
 
Ultrasound findings at presentation 
 
 
Ultrasound findings at last follow-up 
 Normal Stenosis ≤50% 
[n (%)] [n (%)] 
Stenosis 51-80% 
[n (%)] 
Stenosis 81-99% 
[n (%)] 
Occlusion 
[n (%)] 
Stenosis  ≤50% (n=20) 18 (90) 2 (10) - - - 
               51-80% (n=31) 19 (61) 10 (32) 1 (3) - 1 (3) 
               81-99% (n=92) 67 (73) 9 (10) 1 (1) 14 (15) 1 (1) 
Total Occlusion (n=125) 56 (45) 6 (5) 2 (2) 12 (10) 49 (39) 
All (n=268) 160 (60) 27 (10) 4 (1) 26 (10) 51 (19) 
 
Figure 1. Time to Complete Recanalization. 
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